Carlos Andrés Clavijo Prado
Carlos Andrés Clavijo Prado has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Alejandra Chauvez Gallego
Pontificia Universidad Javeriana, Cali
4 shared publicationsArmando Lucumí
Research Department, Department of Medicine and Psychiatry, Research Team Microambiente, Libre University, Cali, Colombia
2 shared publicationsCarlos Steven Marmolejo Escobar
Research Department, Clinical Neuropsychology, Research Team SEMINEC Cooperativa University, Cali, Colombia
2 shared publicationsKaren Julieth Quebrada Mera
Research Department, Clinical Neuropsychology, Research Team SEMINEC Cooperativa University, Cali, Colombia
2 shared publicationsSebastian Ospina Otalvaro
Research Department, Clinical Neuropsychology, Research Team SEMINEC Cooperativa University, Cali, Colombia
2 shared publications- Adriana Martinez-Perez
Department of Neurology, Clínica FOSCAL-Fundación Oftalmológica-Centro Médico Carlos Ardila Lulle, Floridablanca 681004, Colombia
1 shared publication
Latest Publications
- Open Access
How to Implement a Ketogenic Diet Therapy in Developing Countries: Colombian Consensus on Ketogenic Diet Therapy Use in the Management of Adults with Drug-Resistant Epilepsy
Background/Objectives: Drug-resistant epilepsy affects up to one-third of patients with epilepsy and is associated with higher morbidity, mortality, trauma events, psychosocial challenges, and decline in quality of life. In Latin America, disease burden is high and access to advanced therapies remains limited. Ketogenic Diet Therapy (KDT) has been shown to be beneficial in adults, but its implementation requires standardized protocols and experienced multidisciplinary teams. This study aimed to develop practical, evidence-based recommendations to guide the indication, implementation, and follow-up of KDT in adults with drug-resistant epilepsy through expert consensus in Colombia. Methods: A modified version of the Nominal Group Technique was used to develop, discuss, and vote on management concepts. Clinical questions were structured using the PICO framework. Literature searches were conducted in PubMed and EMBASE for articles published since 2015, and the evidence was integrated with the experience of a multidisciplinary expert panel. Results: Twelve recommendations were issued, covering commercial formulas, induction and follow-up protocols, individualized dietary interventions, safety, diagnostic support, nutritional supplementation, and drug-diet interactions. The consensus highlights the need for interdisciplinary teams, structured education, early adherence strategies, and close follow-up, and the role of enteral emergency formulas in intensive care settings. Conclusions: Evidence around KDT shows it can be implemented safely as an adjunctive treatment for adults with drug-resistant epilepsy and is reasonable to consider following the failure of two adequate antiseizure medications. Structured implementation may reduce seizure frequency, improve quality of life, and reduce the pharmacological burden. Multicenter prospective studies are needed to further assess efficacy, safety, and resource utilization. These recommendations contribute to closing the gap between evidence and clinical practice.
Open AccessHow to Implement a Ketogenic Diet Therapy in Developing Countries: Colombian Consensus on Ketogenic Diet Therapy Use in the Management of Adults with Drug-Resistant Epilepsy
Background/Objectives: Drug-resistant epilepsy affects up to one-third of patients with epilepsy and is associated with higher morbidity, mortality, trauma events, psychosocial challenges, and decline in quality of life. In Latin America, disease burden is high and access to advanced therapies remains limited. Ketogenic Diet Therapy (KDT) has been shown to be beneficial in adults, but its implementation requires standardized protocols and experienced multidisciplinary teams. This study aimed to develop practical, evidence-based recommendations to guide the indication, implementation, and follow-up of KDT in adults with drug-resistant epilepsy through expert consensus in Colombia. Methods: A modified version of the Nominal Group Technique was used to develop, discuss, and vote on management concepts. Clinical questions were structured using the PICO framework. Literature searches were conducted in PubMed and EMBASE for articles published since 2015, and the evidence was integrated with the experience of a multidisciplinary expert panel. Results: Twelve recommendations were issued, covering commercial formulas, induction and follow-up protocols, individualized dietary interventions, safety, diagnostic support, nutritional supplementation, and drug-diet interactions. The consensus highlights the need for interdisciplinary teams, structured education, early adherence strategies, and close follow-up, and the role of enteral emergency formulas in intensive care settings. Conclusions: Evidence around KDT shows it can be implemented safely as an adjunctive treatment for adults with drug-resistant epilepsy and is reasonable to consider following the failure of two adequate antiseizure medications. Structured implementation may reduce seizure frequency, improve quality of life, and reduce the pharmacological burden. Multicenter prospective studies are needed to further assess efficacy, safety, and resource utilization. These recommendations contribute to closing the gap between evidence and clinical practice.
- 22 March 2025
- Published by Santiago de Cali University
- p. 207-243
COMPLICACIONES NEUROLÓGICAS POSTERIOR A CIRUGÍA DE REVASCULARIZACIÓN MIOCÁRDICA
Las complicaciones neurológicas representan un reto clínico en el contexto de las cirugías cardíacas, considerando que la frecuencia de realización de estos procedimientos va desde 500 000 hasta 1 millón anuales en el mundo, según datos aportados por la Organización Mundial de la Salud, siendo la revascularización miocárdica (RVM) una de las más frecuentes después del reemplazo valvular y combinación de cirugías como cambio valvular más RVM o miectomía, representando el 10.5 % de todas las cirugías cardíacas según series europeas. Desde la incursión de la circulación extracorpórea (CEC) en 1953 como una herramienta importante que permite mantener la circulación periférica y la oxigenación en condiciones que excluyen al corazón, pero tratan de preservar el mecanismo funcional, se han reportado múltiples complicaciones que impactan la morbimortalidad de los pacientes, con grandes consecuencias sobre el sistema nervioso central y periférico. Estas disfunciones neuropsicológicas varían en incidencia según las diferentes series, pero en promedio oscilan entre el 20-70 % de los pacientes que son llevados a cirugía cardíaca, llegando a ser un 2 a 5 % los que presentan lesiones graves, dando paso a una amplia gama de complicaciones neurológicas, algunas de ellas potencialmente evitables y otras que requieren un reconocimiento oportuno con el objetivo de disminuir secuelas. Es así como desarrollaremos durante el siguiente capítulo tópicos interesantes que abarcan: epidemiología, diagnóstico, aproximación terapéutica y nuevos retos científicos que plantea la práctica clínica diaria, en procura de disminuir la morbimortalidad asociada a estos procedimientos.
- 22 March 2025
- Published by Santiago de Cali University
- p. 207-243
COMPLICACIONES NEUROLÓGICAS POSTERIOR A CIRUGÍA DE REVASCULARIZACIÓN MIOCÁRDICA
Las complicaciones neurológicas representan un reto clínico en el contexto de las cirugías cardíacas, considerando que la frecuencia de realización de estos procedimientos va desde 500 000 hasta 1 millón anuales en el mundo, según datos aportados por la Organización Mundial de la Salud, siendo la revascularización miocárdica (RVM) una de las más frecuentes después del reemplazo valvular y combinación de cirugías como cambio valvular más RVM o miectomía, representando el 10.5 % de todas las cirugías cardíacas según series europeas. Desde la incursión de la circulación extracorpórea (CEC) en 1953 como una herramienta importante que permite mantener la circulación periférica y la oxigenación en condiciones que excluyen al corazón, pero tratan de preservar el mecanismo funcional, se han reportado múltiples complicaciones que impactan la morbimortalidad de los pacientes, con grandes consecuencias sobre el sistema nervioso central y periférico. Estas disfunciones neuropsicológicas varían en incidencia según las diferentes series, pero en promedio oscilan entre el 20-70 % de los pacientes que son llevados a cirugía cardíaca, llegando a ser un 2 a 5 % los que presentan lesiones graves, dando paso a una amplia gama de complicaciones neurológicas, algunas de ellas potencialmente evitables y otras que requieren un reconocimiento oportuno con el objetivo de disminuir secuelas. Es así como desarrollaremos durante el siguiente capítulo tópicos interesantes que abarcan: epidemiología, diagnóstico, aproximación terapéutica y nuevos retos científicos que plantea la práctica clínica diaria, en procura de disminuir la morbimortalidad asociada a estos procedimientos.
- Open Access
- 1 August 2024
- Published by Universidad Libre in Interdisciplinary Journal of Epidemiology and Public Health
- Vol. 7 (2)
La compleja y heterogénea evidencia que describe la biología celular en la neuroinflamación
La neuroinflamación es una integración compleja de las respuestas de todas las células presentes dentro del Sistema nervioso central, incluidas las neuronas, la macroglía, la microglía y los leucocitos infiltrantes. Los trastornos neuroinflamatorias ocurren cuando el sistema inmunológico se vuelve demasiado activo y ataca las células sanas, teniendo una patología de base circundando en sus alrededores. El sistema inmunológico puede dañar partes del sistema nervioso central. La biología celular es amplia a la hora de abordar y definir un cerebro que enfrente una inflamación. Comprender la acción proinflamatoria y antiinflamatoria en el cerebro depende de la microglía y los astrocitos; Varios estudios en animales han identificado marcadores inflamatorios, incluidos el ARNm de IL-1, TNF-α e IL-6. Revisión especial realizada por "Johns Hopkins Medicine International", se concluye que es de suma importancia comprender la neuroinflamación a partir de una lesión isquémica, proponer perspectivas de investigación y reconocer estudios in vitro que permitan buscar terapias alternativas para mejorar a los pacientes.
- 1 August 2024
- Published by Universidad Libre in Interdisciplinary Journal of Epidemiology and Public Health
- Vol. 7 (2)
Open AccessLa compleja y heterogénea evidencia que describe la biología celular en la neuroinflamación
La neuroinflamación es una integración compleja de las respuestas de todas las células presentes dentro del Sistema nervioso central, incluidas las neuronas, la macroglía, la microglía y los leucocitos infiltrantes. Los trastornos neuroinflamatorias ocurren cuando el sistema inmunológico se vuelve demasiado activo y ataca las células sanas, teniendo una patología de base circundando en sus alrededores. El sistema inmunológico puede dañar partes del sistema nervioso central. La biología celular es amplia a la hora de abordar y definir un cerebro que enfrente una inflamación. Comprender la acción proinflamatoria y antiinflamatoria en el cerebro depende de la microglía y los astrocitos; Varios estudios en animales han identificado marcadores inflamatorios, incluidos el ARNm de IL-1, TNF-α e IL-6. Revisión especial realizada por "Johns Hopkins Medicine International", se concluye que es de suma importancia comprender la neuroinflamación a partir de una lesión isquémica, proponer perspectivas de investigación y reconocer estudios in vitro que permitan buscar terapias alternativas para mejorar a los pacientes.
- Open Access
- 1 January 2023
- Published by IMR Press in Revista De Neurologia
- Vol. 76 (07) , 247
Prevalencia de la miastenia grave en Colombia
- 1 January 2023
- Published by IMR Press in Revista De Neurologia
- Vol. 76 (07) , 247
Open AccessPrevalencia de la miastenia grave en Colombia
- Open Access
- 31 December 2022
- Published by Wiley in Case Reports in Medicine
- Vol. 2022, 1-6
Neuropsychiatric Alterations in a Patient Diagnosed with Advanced Korsakoff’s Syndrome: Clinical Case of Low Incidence and Prevalence in Colombia
Korsakoff’s syndrome (KS) is an insidious and progressive neuropsychiatric disorder that affects specific neurocognitive functioning, especially in tasks that require sustained attention, memory, executive functions, and visuospatial functioning. Usually, this disease generates neuropsychiatric complications that worsen the quality of life (QOL) of patients in the medium term. We present a case of a 63-year-old male who presented with a diagnosis of advanced Korsakoff’s syndrome and has a clinical history of recurrent memory loss and a history of alcohol abuse. The patient showed difficulty manipulating immediate information, associated with a possible frontal lobe dysfunction, and inability to remember material given through the auditory pathway. The patient showed a psychiatric clinical picture which is constantly worsening his and his immediate caregiver’s QOL. The data obtained demonstrate that the patient presents a progressive cognitive impairment, which in the short term is correlated with Korsakoff-type dementia. It is suggested to carry out functional neurorehabilitation plans aimed at improving the QOL of the patient, his immediate caregiver, and future people with this type of diagnosis.
- 31 December 2022
- Published by Wiley in Case Reports in Medicine
- Vol. 2022, 1-6
Open AccessNeuropsychiatric Alterations in a Patient Diagnosed with Advanced Korsakoff’s Syndrome: Clinical Case of Low Incidence and Prevalence in Colombia
Korsakoff’s syndrome (KS) is an insidious and progressive neuropsychiatric disorder that affects specific neurocognitive functioning, especially in tasks that require sustained attention, memory, executive functions, and visuospatial functioning. Usually, this disease generates neuropsychiatric complications that worsen the quality of life (QOL) of patients in the medium term. We present a case of a 63-year-old male who presented with a diagnosis of advanced Korsakoff’s syndrome and has a clinical history of recurrent memory loss and a history of alcohol abuse. The patient showed difficulty manipulating immediate information, associated with a possible frontal lobe dysfunction, and inability to remember material given through the auditory pathway. The patient showed a psychiatric clinical picture which is constantly worsening his and his immediate caregiver’s QOL. The data obtained demonstrate that the patient presents a progressive cognitive impairment, which in the short term is correlated with Korsakoff-type dementia. It is suggested to carry out functional neurorehabilitation plans aimed at improving the QOL of the patient, his immediate caregiver, and future people with this type of diagnosis.
- Open Access
- 15 November 2022
- Published by Universidad FUCS in Repertorio de Medicina y Cirugía
- Vol. 31 (3) , 275-282
Aproximación diagnóstica de la neurosífilis
Neurosyphilis (NS) is a disease affecting the central nervous system (CNS) caused by the spirochete bacteria Treponema pallidum; it may occur in immunocompetent patients but it more generally presents in patients with human immunodeficiency virus (HIV). The latter are more severe cases featuring a wide variety of neurological manifestations. Although the typical form is the most common, there are atypical expressions that may occur in 30% of cases as evidenced by neuroimaging studies, so recognition is important in order to ensure an early diagnosis and timely intervention. It is not only a public health problem due to its prevalence but also because of the broad clinical spectrum for which it has been called the great imitator. However, primary care physicians may not be aware of these manifestations. The following work has been proposed based on three clinical cases (two patients with CNS vasculitis and one with panuveitis) with the aim of demystifying NS forms of presentation and clarifying clinical manifestations involving the CNS, to perform an accurate diagnosis and initiate a proper and timely treatment to reduce sequelae.
- 15 November 2022
- Published by Universidad FUCS in Repertorio de Medicina y Cirugía
- Vol. 31 (3) , 275-282
Open AccessAproximación diagnóstica de la neurosífilis
Neurosyphilis (NS) is a disease affecting the central nervous system (CNS) caused by the spirochete bacteria Treponema pallidum; it may occur in immunocompetent patients but it more generally presents in patients with human immunodeficiency virus (HIV). The latter are more severe cases featuring a wide variety of neurological manifestations. Although the typical form is the most common, there are atypical expressions that may occur in 30% of cases as evidenced by neuroimaging studies, so recognition is important in order to ensure an early diagnosis and timely intervention. It is not only a public health problem due to its prevalence but also because of the broad clinical spectrum for which it has been called the great imitator. However, primary care physicians may not be aware of these manifestations. The following work has been proposed based on three clinical cases (two patients with CNS vasculitis and one with panuveitis) with the aim of demystifying NS forms of presentation and clarifying clinical manifestations involving the CNS, to perform an accurate diagnosis and initiate a proper and timely treatment to reduce sequelae.
- Open Access
- 11 November 2022
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 14 (3) , 441-455
Case Report: Three Case Reports of Rapidly Progressive Dementias and Narrative Review
Rapidly progressive dementia (RPD) is a heterogeneous group of diseases characterized by cognitive impairment and other neurological disorders developed in a short span of fewer than 2 years. Currently viewed as new and infrequent entities, most medical personnel have little understanding of it. Nevertheless, they significantly compromise many patients’ quality of life. Here, we drive 3 clinical cases that evolve as RPD with different etiologies. Case 1:70-year-old woman presented to the emergency with neuropsychiatric syndrome for 18 days. The researchers identified inflammatory cerebrospinal fluid (CSF), protein 14-3-3-positive T-tau protein, MRI: T2 and FLAIR hyperintensities in bilateral caudate nuclei with diffusion restriction, EEG shows a generalized periodic pattern with triphasic wave morphology. Case 2:29-year-old man with cognitive impairment and faciobrachial dystonia seizure. The diagnosis was confirmed by achieving elevated antibodies against voltage-gated potassium channels. Case 3:A 49-year-old woman with encephalopathy and myoclonic seizures; EEG and MRI showed subtle changes. The patient also had a normal CSF but a positive CBA serologic NMDA-R antibody test. We described fundamental aspects of RPD to allow made differential diagnoses in patients with cognitive impairment and encephalopathy. Establishing an early and accurate diagnosis can benefit patients with RPD etiologies that are treatable and even reversible, decreasing in morbidity and mortality.
- 11 November 2022
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 14 (3) , 441-455
Open AccessCase Report: Three Case Reports of Rapidly Progressive Dementias and Narrative Review
Rapidly progressive dementia (RPD) is a heterogeneous group of diseases characterized by cognitive impairment and other neurological disorders developed in a short span of fewer than 2 years. Currently viewed as new and infrequent entities, most medical personnel have little understanding of it. Nevertheless, they significantly compromise many patients’ quality of life. Here, we drive 3 clinical cases that evolve as RPD with different etiologies. Case 1:70-year-old woman presented to the emergency with neuropsychiatric syndrome for 18 days. The researchers identified inflammatory cerebrospinal fluid (CSF), protein 14-3-3-positive T-tau protein, MRI: T2 and FLAIR hyperintensities in bilateral caudate nuclei with diffusion restriction, EEG shows a generalized periodic pattern with triphasic wave morphology. Case 2:29-year-old man with cognitive impairment and faciobrachial dystonia seizure. The diagnosis was confirmed by achieving elevated antibodies against voltage-gated potassium channels. Case 3:A 49-year-old woman with encephalopathy and myoclonic seizures; EEG and MRI showed subtle changes. The patient also had a normal CSF but a positive CBA serologic NMDA-R antibody test. We described fundamental aspects of RPD to allow made differential diagnoses in patients with cognitive impairment and encephalopathy. Establishing an early and accurate diagnosis can benefit patients with RPD etiologies that are treatable and even reversible, decreasing in morbidity and mortality.
- 1 February 2021
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 85, 42-44
Insular epilepsy as a great imitator: A case report
- 1 February 2021
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 85, 42-44
Insular epilepsy as a great imitator: A case report
- Open Access
- 7 December 2020
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 10 (6) , 206-208
Symptomatic seizure and covid-19: A case report
- 7 December 2020
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 10 (6) , 206-208
Open AccessSymptomatic seizure and covid-19: A case report
- Open Access
- 7 May 2019
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 9 (3) , 62-65
Autoimmune epilepsy—a new goal of science: report of two cases in the San Jose Hospital, Bogota, Colombia
Despite the fact that epilepsy is the third most common chronic brain disorder, relatively little is known about the processes leading to the generation of seizures. The constant advancement in technology and continuous research in epilepsy field has led the investigators to important discoveries like the immune mediated mechanisms for certain types of epilepsy. This is particularly hypothesized in patients with epilepsy of acute or subacute onset, poor responders to antiepileptic drugs, and those presenting cognitive changes or encephalopathy. A wide range of antibodies has been described in relation to the development of the disease. The following two cases were known at the San Jose Hospital in Bogota, Colombia. In this opportunity, it would be of interest to review the following cases presented at HSJ in Bogota.
- 7 May 2019
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 9 (3) , 62-65
Open AccessAutoimmune epilepsy—a new goal of science: report of two cases in the San Jose Hospital, Bogota, Colombia
Despite the fact that epilepsy is the third most common chronic brain disorder, relatively little is known about the processes leading to the generation of seizures. The constant advancement in technology and continuous research in epilepsy field has led the investigators to important discoveries like the immune mediated mechanisms for certain types of epilepsy. This is particularly hypothesized in patients with epilepsy of acute or subacute onset, poor responders to antiepileptic drugs, and those presenting cognitive changes or encephalopathy. A wide range of antibodies has been described in relation to the development of the disease. The following two cases were known at the San Jose Hospital in Bogota, Colombia. In this opportunity, it would be of interest to review the following cases presented at HSJ in Bogota.